We suggest that the Vglut2flox/flox;CamKII-Cre mice may function as a genetic hypoglutamate model of schizophrenia-like behaviour and may be of use for validation of new psychopharmacological drugs. The gene discussed is CAMK2G; the disease is schizophrenia.